🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Rhomboid Intercostal Block Versus Retrolaminar Block for Postoperative Analgesia After Thoracoscopic Sympathectomy

RecruitingNAAges 18 Years - 60 YearsAllDamanhour Teaching Hospital
NCT06653803 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Background: Although thoracoscopic sympathectomy is made via small incisions, it is associated with severe postoperative pain. Both Rhomboid intercostal block (RIB) and Retrolaminar block (RLB) are recent techniques used for pain control after such procedures Objectives: To compare the effectiveness of RIB and RLB in providing postoperative analgesia after thoracoscopic sympathectomy in adult patients and their impact on the patient's outcomes. Patients and Methods: This prospective, randomized (1:1), double-blind clinical trial; will be carried out on 60 patients scheduled for elective thoracoscopic sympathectomy under general anesthesia at our hospital. Patients will be randomly allocated into two equal groups (30 patients each) and will receive: in group A; general anesthesia with intraoperative ipsilateral ultrasound-guided RIB, whereas in group B; general anesthesia with intraoper

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * American Society of Anesthesiologists (ASA) physical status ≤ II * Age from 18 to 60 years * Body Mass Index (BMI) \< 35 kg/m² Exclusion Criteria: * American Society of Anesthesiologists (ASA) physical status \> II * Age \< 18 years or \> 60 years * Body Mass Index (BMI) ≥ 35 * Local infection at the puncture site * Altered mental status * Pregnant women * Allergy to study drugs * Chronic pain * Coagulation abnormalities or on anticoagulants * Severe hepatic or kidney disease
💊

What it tests

  • Rhomboid Intercostal Block (RIB)
  • Retrolaminar Block (RLB)
📍

Where

1 site
Damanhour Teaching Hospital
Damanhūr, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy